Growth in genetic applications and reduction in the cost of sequencing is driving the market for consumer genomics.
The global Consumer Genomics market is forecast to reach USD 6.58 Billion by 2027, according to a new report by Reports and Data. The growing demand for in-depth knowledge of consumer’s ancestry and a reduction in the price of genetic procedures are boosting the growth of the market.
The market is witnessing an increased demand owing to the massive change in technology. The development of innovative machines and increased spending on research is further propelling the demand. The government is taking initiatives to encourage the growth of the market. The growing trend of personalized medicine is also another trend impacting market demand. However, the high cost of the genomic instruments and regulatory guidelines are hampering the growth of the market.
Advancement in genomics will continue to give rise to the economic, environmental, and ethical, legal, and social implications, all of which will garner attention from the public and the policymakers. Several healthcare and research companies are working towards the integration of genomic data, while major clinical centers like Stanford Health Care and many cancer research centers are using genomic data to personalize treatments for treating life-threatening diseases such as cancer.
The Covid-19 Impact
The market will witness a huge surge as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A significant number of biotech firms are in the middle of the race to investigate the virus’s genome and are preparing a viable vaccine. These companies are investigating the virus at an unprecedented rate, and considerable funds are being put into the research. The companies are in trial, and the public and private sectors are working continuously for the development of the vaccine.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3493
Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.
Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2027.
The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.
This report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts.
Further key findings from the report suggest
Pharmaceutical companies are making use of the available genomic information in personalized medicine, which is forecasted to significantly impact the growth of the market. The reduction in the cost of sequencing has enabled the whole genome sequencing at a very affordable price, which has made it more attractive to pharmaceutical and biotechnology companies.
Polymerase chain reaction (PCR) has several advantages, which is boosting the demand for the market. The reaction is simple, easy to understand, and also produces results quickly. The technique is very sensitive, with the potential to produce billions of copies of a certain product for cloning, sequencing, and analysis. Thus, it finds its use in analyzing alterations of gene expression levels in tumors, microbes, or other disease states.
The growing trend of linking ancestors with consumer genetic tests that are available to the users directly through the internet is driving the demand for the market. These tests use the raw DNA of the consumers to gain information pertaining to hereditary diseases and the response of drugs on the individual’s heath.
North America is witnessing a growth in the market owing to the increasing research funding and government initiatives in genomics. Government support, presence of advanced healthcare facilities, and changing regulations for reimbursement and usage are expected to propel the adoption of consumer genetic tests in the region.
Key participants include 23andMe, Inc., Ancestry, Mapmygenome, Gene By Gene, Ltd. (FamilyTree DNA), Color Genomics, Inc., Futura Genetics, Positive Biosciences, Ltd., Helix OpCo LLC, Pathway Genomics, and MyHeritage Ltd, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3493
For the purpose of this report, Reports and Data have segmented into the global Consumer Genomics market on the basis of the product and services, technology, application, and region:
Product and Services Outlook (Revenue, USD Billion; 2017-2027)
System and Software
Technology Outlook (Revenue, USD Billion; 2017-2027)
Nucleic Acid Extraction and Purification
Application Outlook (Revenue, USD Billion; 2017-2027)
Lifestyle, Wellness, & Nutrition
Sports Nutrition & Health
Personalized Medicine & Pharmacogenetic Testing
Regional Outlook (Revenue, USD Billion; 2017-2027)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3493
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized as per your requirements.
Read More Reports:-
Immunoprecipitation Market @ https://www.reportsanddata.com/report-detail/immunoprecipitation-market
Immunofluorescence Assay (IFA) Market @ https://www.reportsanddata.com/report-detail/immunofluorescence-assay-ifa-market
Microbial and Bacterial Cellulose Production Market @ https://www.reportsanddata.com/report-detail/microbial-and-bacterial-cellulose-production-market
Thyroid Function Tests Market @ https://www.reportsanddata.com/report-detail/thyroid-function-tests-market
Medical Holographic Imaging Market @ https://www.reportsanddata.com/report-detail/medical-holographic-imaging-market
Cellular Health Screening Market @ https://www.reportsanddata.com/report-detail/cellular-health-screening-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370